Edgewise Therapeutics, Inc. EWTX 深 沪
已收盘 05-15 16:00:00 美东时间
33.09
-0.920
-2.71%
华盛通- 最 高33.95
- 今 开33.81
- 成交量 98.92万股
- 最 低 32.76
- 昨 收 34.01
- 总市值 35.58亿
- 52周最高 39.96
- 市盈率 静 --
- 换手率 0.92%
- 52周最低 12.15
- 委 比 35.14%
- 总股本 1.08亿
- 历史最高 40.49
- 量 比 0.94
- 振 幅 3.50%
- 历史最低 5.12
- 每 手 1
- 风险率 7.46%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多财报速睇 | Edgewise Therapeutics, Inc. 2026财年Q1营收0.00亿美元，同比增长0.0%；归母净利润亏损0.49亿美元，同比亏损扩大19.5%
华盛资讯5月7日讯，Edgewise Therapeutics, Inc.公布2026财年Q1业绩，公司Q1营收0.00亿美元，同比增长0.0%，归母净利润亏损0.49亿美元，同比亏损扩大19.5%。
05-07 20:36
Edgewise Therapeutics GAAP EPS of -$0.46
Edgewise Therapeutics press release (EWTX): Q1 GAAP EPS of -$0.46. Cash, cash equivalents and marketable securities were approximately $499.6 million as of March 31, 2026. Research and development (R&...
05-07 20:27
Edgewise Therapeutics Q1 EPS $(0.46) Beats $(0.50) Estimate
Edgewise Therapeutics (NASDAQ:EWTX) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0.50) by 8 percent. This is a 6.98 percent decrease over losses of $(0.43) per share from
05-07 20:18
Rockwell Automation Posts Upbeat Q2 Results, Joins EverQuote, DigitalOcean And Other Big Stocks Moving Higher On Tuesday
Dow Jones up 200 points, Rockwell Automation shares rise 10.8% on strong earnings and raised guidance. Other big gainers include EverQuote, Sterling Infrastructure, and DigitalOcean.
05-05 23:58
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Cellectar Biosciences (NASDAQ:CLRB) stock moved upwards by 45.0% to $4...
05-05 20:06
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
BOULDER, Colo., May 4, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc. ("Edgewise" or the "Company"), (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company developing novel the...
05-04 20:00
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
BOULDER, Colo., April 1, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc. ("Edgewise" or the "Company"), (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company developing novel t...
04-01 20:00
Edgewise CMO Joanne Donovan disposes of $685k common shares
Edgewise CMO Joanne Donovan disposes of $685k common shares Edgewise Therapeutics CMO Joanne M. Donovan sold 21,338 shares on March 31, 2026 at an average price of $32.12. The transaction followed an option exercise of 21,338 shares at $7.08. Donovan held 9,597 shares directly following the transact
04-01 09:31
美股大行评级 | 摩根大通上调哔哩哔哩至"超配"，目标价从27美元升至35美元；Rhythm遭花旗、大摩等多家机构下调目标价
今日重点评级关注：韦德布什：维持Black Diamond Therapeutic"跑赢大市"评级，目标价从13美元升至14美元；花旗：维持Olema Pharmaceuticals"买入"评级，目标价从60美元升至62美元
03-18 10:48
Wedbush Reiterates Outperform on Edgewise Therapeutics, Maintains $32 Price Target
Wedbush analyst Laura Chico reiterates Edgewise Therapeutics (NASDAQ:EWTX) with a Outperform and maintains $32 price target.
03-17 20:25
